Springboard Corner: October 2023

Oct 4, 2023


Welcome To The Springboard Corner

The Springboard Corner is your go-to source for the latest updates on the remarkable journey of life science and hi-tech startups that have participated in Connect’s Springboard program. We are thrilled to share the most recent milestones achieved by these extraordinary Springboard companies. So, stick around, and let’s dive into the inspiring stories of innovation and progress!

springboard corner 100223

Carlsmed – which has developed a patented medical device that is combined with a personalized surgical plan for patients needing spine surgery, recently announced that the FDA (Food and Drug Administration) has granted Breakthrough Device designation for their aprevoR technology. This is the company’s second Breakthrough Device designation. (Highlighted November 2022)

Inhibrx – a clinical stage biotech company developing cancer and rare disease therapeutics, recently announced that the company will retain its rights to INBRX-101 for commercialization outside of the U.S. and Canada. This came about when Chiesi Farmaceutici S.p.A. turned down the right to exercise its option. INBRX-101, which received Fast Track Designation by the FDA earlier this year, is their drug candidate to treat patients suffering from a specific type of emphysema. (Highlighted September 2023)

MyoGene Bio – an early-stage biotech company developing gene editing therapies to treat muscle diseases, CEO and Co-Founder Courtney Young, was recently recognized as one of MIT Technology Review’s Under 35 Innovators for 2023. This annual award showcases promising young innovators who have the potential to make groundbreaking contributions which will impact the world. Congratulations Courtney! (Highlighted Summer 2023)

Nascent Biotech – a clinical stage biopharma company which is developing monoclonal antibodies, recently announced that the FDA (Food and Drug Administration) has given them the green light to begin Phase-II clinical trials for brain cancer with their lead candidate, Pritumumab. (Highlighted Summer 2022)

tab32 – founded in 2013, the company is a pioneer in developing a comprehensive cloud-based, HIPAA-compliant, technology management platform used by dental practitioners for their patients’ dental electronic health records (Dental EHR). They have received numerous accolades, most recently being featured on Google Healthcare as a Dental Market solutions provider.

The Springboard Corner Is Powered By:


Thank you for delving into the latest installment of Springboard Corner this month. Stay tuned for the upcoming updates and remarkable achievements that await as Connect’s Springboard Companies continue to shape the future!